
Fosfomycin not noninferior to comparators for bacteremic UTI
(HealthDay)—For patients with bacteremic urinary tract infections (bUTIs) due to multidrug-resistant (MDR) Escherichia coli, fosfomycin is not noninferior to comparators, with an increased rate of adverse event-related ...
Jan 14, 2022
0
3